View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

DOJ/DEA RIN: 1117-AA51 Publication ID: Spring 2000 
Title: ●Schedules of Controlled Substances: Exempt Anabolic Steroid Products 
Abstract: The Drug Enforcement Administration (DEA) is designating six preparations as exempt anabolic steroid products. This action, as part of the ongoing implementation of the Anabolic Steroids Control Act of 1990, removes certain regulatory controls pertaining to Schedule III substances from the designated entities. 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
EO 13771 Designation: uncollected 
CFR Citation: 21 CFR 1308   
Legal Authority: 21 USC 811    21 USC 812    21 USC 871(b)   
Legal Deadline:  None
Action Date FR Cite
Interim Final Rule  01/20/2000  65 FR 3124   
Interim Final Rule Effective  01/20/2000    
Interim Final Rule Comment Period End  03/20/2000    
Final Action  10/00/2000    
Additional Information: DEA-187
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
Agency Contact:
Frank Sapienza
Chief, Drug and Chemical Evaluation Section
Department of Justice
Drug Enforcement Administration
Office of Diversion Control,
Washington, DC 20537
Phone:202 307-7183